|
DE257197C
(OSRAM)
|
|
|
|
|
|
DE286509C
(OSRAM)
|
|
|
|
|
|
US3914252A
(en)
|
1971-03-15 |
1975-10-21 |
Continental Oil Co |
Preparation of N-iodocompounds
|
|
DD257197A1
(de)
|
1987-01-28 |
1988-06-08 |
Univ Dresden Tech |
Verfahren zur herstellung von immobilisierten, in ihrer biologischen aktivitaet stabilisierten und in ihren pharmakologischen eigenschaften modifizierten insulinpraeparationen
|
|
DK105489D0
(da)
|
1989-03-03 |
1989-03-03 |
Novo Nordisk As |
Polypeptid
|
|
DD286509A5
(de)
|
1989-06-30 |
1991-01-31 |
Veb Berlin-Chemie,De |
Verfahren zur herstellung von aktivitaetsstabilisierten, wirkungsverlaengerten rektal applizierbaren insulinpraeparationen
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
CA2095633C
(en)
|
1990-12-03 |
2003-02-04 |
Lisa J. Garrard |
Enrichment method for variant proteins with altered binding properties
|
|
ZA954983B
(en)
|
1994-06-17 |
1996-02-14 |
Novo Nordisk As |
N-terminally extended proteins expressed in yeast
|
|
US6500645B1
(en)
|
1994-06-17 |
2002-12-31 |
Novo Nordisk A/S |
N-terminally extended proteins expressed in yeast
|
|
DK0851925T3
(da)
|
1995-09-21 |
2005-11-28 |
Genentech Inc |
Humane Væksthormonvarianter
|
|
AU5065198A
(en)
|
1996-11-15 |
1998-06-10 |
Maria Grazia Masucci |
Fusion proteins having increased half-lives
|
|
WO1998028429A1
(en)
|
1996-12-20 |
1998-07-02 |
Novo Nordisk A/S |
N-terminally extended proteins expressed in yeast
|
|
IL133974A0
(en)
|
1997-07-14 |
2001-04-30 |
Bolder Biotechnology Inc |
Derivatives of growth hormone and related proteins
|
|
JP4944324B2
(ja)
|
1999-07-13 |
2012-05-30 |
ボルダー バイオテクノロジー， インコーポレイテッド |
免疫グロブリン融合タンパク質
|
|
US20050287153A1
(en)
|
2002-06-28 |
2005-12-29 |
Genentech, Inc. |
Serum albumin binding peptides for tumor targeting
|
|
JP2003518075A
(ja)
|
1999-12-24 |
2003-06-03 |
ジェネンテック・インコーポレーテッド |
生理活性化合物の消失半減期延長のための方法及び組成物
|
|
US20060183197A1
(en)
|
2001-01-11 |
2006-08-17 |
Andersen Kim V |
Variant growth hormone molecules conjugated with macromolecules compounds
|
|
WO2002055532A2
(en)
|
2001-01-11 |
2002-07-18 |
Maxygen Aps |
Variant growth hormone molecules conjugated with macromolecular compounds
|
|
PE20020908A1
(es)
|
2001-03-21 |
2002-10-26 |
Cell Therapeutics Inc |
Produccion recombinante de polimeros polianionicos y uso de de los mismos
|
|
MXPA04004385A
(es)
|
2001-11-12 |
2004-11-29 |
Univ Cardiff |
Variaciones de hormona de crecimiento en humanos y sus usos.
|
|
GB2384001B
(en)
|
2001-12-14 |
2004-02-04 |
Asterion Ltd |
Chimeric growth hormone-growth hormone receptor proteins
|
|
EP2298805A3
(en)
|
2002-09-27 |
2011-04-13 |
Xencor, Inc. |
Optimized Fc variants and methods for their generation
|
|
US20040180054A1
(en)
|
2003-03-13 |
2004-09-16 |
Hanmi Pharm. Co., Ltd. |
Physiologically active polypeptide conjugate having prolonged in vivo half-life
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
JP4762904B2
(ja)
|
2003-11-13 |
2011-08-31 |
ハンミ ホールディングス カンパニー リミテッド |
免疫グロブリン不変領域の量産方法
|
|
KR100594607B1
(ko)
|
2004-11-03 |
2006-06-30 |
재단법인서울대학교산학협력재단 |
신규한 경구투여용 재조합 인간 성장호르몬 분비미생물제제 및 그 제조방법
|
|
US7998930B2
(en)
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
|
JP5735194B2
(ja)
|
2005-01-25 |
2015-06-17 |
セル セラピューティクス インコーポレーテッド |
改善された生体内半減期を有する生物学的に活性なタンパク質
|
|
ZA200707006B
(en)
*
|
2005-01-25 |
2008-11-26 |
Cell Therapeutics Inc |
Conjugates of biologically active proteins having a modified in vivo half-life
|
|
WO2006079641A2
(en)
|
2005-01-27 |
2006-08-03 |
Novo Nordisk A/S |
Insulin derivatives conjugated with structurally well defined branched polymers
|
|
BRPI0607775A2
(pt)
|
2005-02-16 |
2018-06-26 |
Novo Nordisk As |
conjugado, composição farmacêutica, uso de um composto, e, método para o tratamento ou prevenção de doença
|
|
KR100754667B1
(ko)
|
2005-04-08 |
2007-09-03 |
한미약품 주식회사 |
비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
|
|
JP5255435B2
(ja)
|
2005-04-26 |
2013-08-07 |
メディミューン，エルエルシー |
ヒンジドメイン操作による抗体エフェクター機能の調節
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
WO2007103515A2
(en)
|
2006-03-06 |
2007-09-13 |
Amunix, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
GB2446088B
(en)
|
2005-12-12 |
2010-10-20 |
Innova Biosciences Ltd |
Production of conjugates
|
|
US8334257B2
(en)
|
2005-12-20 |
2012-12-18 |
Duke University |
Methods and compositions for delivering active agents with enhanced pharmacological properties
|
|
WO2008019368A2
(en)
|
2006-08-07 |
2008-02-14 |
Teva Biopharmaceuticals Usa, Inc. |
Albumin-insulin fusion proteins
|
|
ES2410886T3
(es)
|
2006-10-26 |
2013-07-03 |
Janssen Biotech, Inc. |
Métodos para la adaptación al ser humano de anticuerpos monoclonales
|
|
WO2008049711A1
(en)
*
|
2006-10-27 |
2008-05-02 |
Novo Nordisk A/S |
Peptide extended insulins
|
|
US20100303723A1
(en)
|
2006-11-20 |
2010-12-02 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
|
WO2008092117A2
(en)
|
2007-01-25 |
2008-07-31 |
Xencor, Inc. |
Immunoglobulins with modifications in the fcr binding region
|
|
KR20080095141A
(ko)
|
2007-04-23 |
2008-10-28 |
포항공과대학교 산학협력단 |
인간 알부민 링커를 통하여 면역글로불린의 Ｆｃ에 결합된생리학적 활성 폴리펩티드의 융합 폴리펩티드, 및 이의제조방법
|
|
CN105198998A
(zh)
|
2007-05-30 |
2015-12-30 |
浦项工科大学校产学协力团 |
免疫球蛋白融合蛋白
|
|
JP6071165B2
(ja)
|
2007-05-31 |
2017-02-01 |
ゲンマブ エー／エス |
安定なＩｇＧ４抗体
|
|
WO2009015345A1
(en)
|
2007-07-25 |
2009-01-29 |
Amgen Inc. |
Pharmaceutical compositions comprising fc fusion proteins
|
|
BRPI0815416A2
(pt)
*
|
2007-08-15 |
2014-10-21 |
Amunix Inc |
Composições e métodos para modificar propriedades de polipeptídeos biologicamente ativos
|
|
ES2400107T3
(es)
|
2007-10-22 |
2013-04-05 |
Merck Serono S.A. |
IFN-beta sencillo fusionado a un fragmento Fc de lgG mutado
|
|
MX2010014079A
(es)
|
2008-06-20 |
2011-02-22 |
Novartis Ag |
Inmunoglobulinas con agregacion reducida.
|
|
WO2010001196A1
(en)
|
2008-07-02 |
2010-01-07 |
Koninklijke Philips Electronics N.V. |
V-spring configuration and end attachment assemblies therefor for use in a personal care appliance
|
|
ES2523043T3
(es)
|
2008-07-23 |
2014-11-20 |
Hanmi Science Co., Ltd. |
Un complejo polipeptídico que comprende un polímero no peptidílico que tiene tres extremos funcionales
|
|
PL2393828T3
(pl)
*
|
2009-02-03 |
2017-06-30 |
Amunix Operating Inc. |
Wydłużone rekombinowane polipeptydy i zawierające je kompozycje
|
|
GB0914110D0
(en)
|
2009-08-12 |
2009-09-16 |
Medical Res Council |
Peptide libraries
|
|
SG10201406063XA
(en)
|
2009-09-30 |
2014-11-27 |
Glaxo Group Ltd |
Drug fusions and conjugates with extended half life
|
|
AU2010318542B2
(en)
|
2009-10-29 |
2015-08-27 |
Janssen Biotech Inc. |
Antibody glycosylation variants
|
|
US8637637B2
(en)
|
2010-01-12 |
2014-01-28 |
Bill Nai-Chau Sun |
Fc fusion proteins of human growth hormone
|
|
AR081066A1
(es)
|
2010-04-02 |
2012-06-06 |
Hanmi Holdings Co Ltd |
Conjugado de insulina donde se usa un fragmento de inmunoglobulina
|
|
SI2571510T1
(sl)
|
2010-05-21 |
2019-02-28 |
Xl-Protein Gmbh |
Biosintetični prolin/alaninski naključno zviti polipeptidi in njihove uporabe
|
|
KR101337797B1
(ko)
|
2010-07-14 |
2013-12-06 |
한미사이언스 주식회사 |
지속형 인간 성장 호르몬 결합체 액상 제제
|
|
WO2012138920A1
(en)
|
2011-04-05 |
2012-10-11 |
Martin-Protean, Llc |
Isolation of cysteine containing peptides
|
|
UA117901C2
(uk)
|
2011-07-06 |
2018-10-25 |
Ґенмаб Б.В. |
Спосіб посилення ефекторної функції вихідного поліпептиду, його варіанти та їх застосування
|
|
MX366864B
(es)
|
2012-02-27 |
2019-07-26 |
Amunix Operating Inc |
Composiciones de conjugados de xten y métodos para realizarlas.
|
|
US9545449B2
(en)
|
2012-05-11 |
2017-01-17 |
Advanced Proteone Therapeutics Inc. |
Site-specific labeling and targeted delivery of proteins for the treatment of cancer
|
|
CN105308067B
(zh)
|
2013-06-07 |
2020-07-24 |
诺和诺德股份有限公司 |
制备成熟胰岛素多肽的方法
|
|
JP6822839B2
(ja)
|
2013-09-13 |
2021-01-27 |
ザ・スクリップス・リサーチ・インスティテュート |
修飾された治療剤、及びその組成物
|
|
EP4053560A1
(en)
|
2013-11-26 |
2022-09-07 |
The Brigham and Women's Hospital, Inc. |
Compositions and methods for modulating an immune response
|
|
TW201619188A
(zh)
|
2014-03-05 |
2016-06-01 |
優稀美生物醫藥公司 |
多聚體Ｆｃ蛋白質
|
|
EP3194447B1
(en)
|
2014-09-17 |
2021-12-01 |
Novo Nordisk A/S |
Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (1-161)
|
|
CN107810202A
(zh)
|
2015-02-17 |
2018-03-16 |
韩美药品株式会社 |
长效胰岛素或胰岛素类似物复合物
|
|
AR105616A1
(es)
|
2015-05-07 |
2017-10-25 |
Lilly Co Eli |
Proteínas de fusión
|
|
CN107743494B
(zh)
|
2015-06-02 |
2022-04-29 |
诺和诺德股份有限公司 |
具有极性重组延伸体的胰岛素
|
|
WO2017031034A2
(en)
|
2015-08-14 |
2017-02-23 |
Rc Biotechnologies, Inc. |
Covalent linkers in antibody-drug conjugates and methods of making and using the same
|
|
MA43348A
(fr)
|
2015-10-01 |
2018-08-08 |
Novo Nordisk As |
Conjugués de protéines
|
|
JP2020513019A
(ja)
|
2017-04-05 |
2020-04-30 |
ノヴォ ノルディスク アー／エス |
オリゴマー伸長インスリン−Ｆｃコンジュゲート
|